Major Interest in Shares

RNS Number : 3078P

Oxford Biomedica PLC

23 March 2009

 



For immediate release

23 March 2009

Oxford BioMedica Plc

Notification of Major Interest in Shares

Oxford, UK -     23 March 2009: Oxford BioMedica (LSE:OXB), a leading gene therapy company, announces that Spreadex Limited has acquired an interest in its ordinary share capital amounting to 3.13 per cent of presently issued shares. This is connected with the change in interest in Oxford BioMedica by Credit Agricole Cheuvreux International Limited that was announced on 20 March 2009. Spreadex Limited has converted a Contract For Difference (CFD) over Oxford BioMedica plc shares into a fully paid up holding of the underlying stock. 

TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:						Oxford BioMedica Plc
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights									Yes
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):______________
3. Full name of person(s) subject to notification obligation:				Spreadex Limited
4. Full name of shareholder(s) (if different from 3):
5. Date of transaction (and date on which the threshold is crossed or reached if different):				18/03/09
6. Date on which issuer notified:				20/03/09
7. Threshold(s) that is/are crossed or reached:				3%
8: Notified Details
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code GB0006648157	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares 0	Number of voting rights 0	Number of shares 16,880,025		Number of voting rights			Percentage of voting rights
					Direct 16,880,025		Indirect -	Direct 3.13%		Indirect -

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights

Total (A+B)
Number of voting rights	Percentage of voting rights
16,880,025	3.13%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14 Contact name:	Andrew Wood
15. Contact telephone name:	01865 783000

 

END

 

 

HOLILFISVSIVFIA